Abstract
Psychological stress is proposed to be an evolutionary adaptation to the flight or fight response. Physiological changes occur in a number of systems during psychological stress, including the immune response. Classically, acute psychological stress leads to activation of the immune response and chronic psychological stress leads to suppression of the immune response. Skin is the outer most barrier of the body and possesses both innate and adaptive immune responses. Because many dermatological diseases have an immune system component (e.g., atopic dermatitis) we will assess the impact of psychological stress on the skin immune responses herein. Psychological stress has been reported to affect both the innate and adaptive immune responses in experimental systems and in skin disease states. A number of mechanisms have been proposed to explain how psychological stress exerts its impact on the skin immune response including redistribution of the lymphocytes, modulation of immune cell functions and differential expression of cytokines. Although rare, psychtropic drugs can also cause unwanted skin pathologies. The finding that adverse reactions of psychotropic drugs are related to major histocompatability haplotype may suggest an immune mechanism of action. On the other hand, some drugs used to treat skin diseases can results in psychiatric disorders. Finally, a number of psychological methods have been used to successfully treat or reduce the symptoms of skin diseases including hypnosis, cognitive behavioral therapy, psychotherapy and biofeedback.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aberg KM, Radek KA, Choi EH, Kim DK, Demerjian M, Hupe M, Kerbleski J, Gallo RL, Ganz T, Mauro T, Feingold KR, Elias PM (2007) Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 117:3339–3349
Arndt KA, Jick H (1976) Rates of cutaneous reactions to drugs. a report from the Boston Collaborative Drug Surveillance Program. JAMA 235:918–923
Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, Vasiadi M, Zhang B, Kalogeromitros D, Theoharides TC (2012) Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol 132:324–329
Banks WA, Kastin AJ, Gutierrez EG (1994) Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 179:53–56
Bartrop RW, Luckhurst E, Lazarus L, Kiloh LG, Penny R (1977) Depressed lymphocyte function after bereavement. Lancet 1:834–836
Bernardini R, Chiarenza A, Kamilaris TC, Renaud N, Lempereur L, Demitrack M, Gold PW, Chrousos GP (1994) In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology 60:503–508
Bowers SL, Bilbo SD, Dhabhar FS, Nelson RJ (2008) Stressor-specific alterations in corticosterone and immune responses in mice. Brain Behav Immun 22:105–113
Buske-Kirschbaum A, Geiben A, Hollig H, Morschhauser E, Hellhammer D (2002a) Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 87:4245–4251
Buske-Kirschbaum A, Gierens A, Hollig H, Hellhammer DH (2002b) Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 129:161–167
Calogero AE, Bernardini R, Margioris AN, Bagdy G, Gallucci WT, Munson PJ, Tamarkin L, Tomai TP, Brady L, Gold PW (1989) Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10:189–200
Cannon WB (1914) The emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol 33:356–372
Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL, Theoharides TC (2005) Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 174:7665–7675
Castell JV, Andus T, Kunz D, Heinrich PC (1989a) Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann NY Acad Sci. 557, 87–99 (discussion 100-1)
Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC (1989b) Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237–239
Chadwick D, Shaw MD, Foy P, Rawlins MD, Turnbull DM (1984) Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. J Neurol Neurosurg Psychiatry 47:642–644
Choi EH, Brown BE, Crumrine D, Chang S, Man MQ, Elias PM, Feingold KR (2005) Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 124:587–595
Clausen BE, Kel JM (2010) Langerhans cells: critical regulators of skin immunity? Immunol Cell Biol 88:351–360
Cowen T, Trigg P, Eady RA (1979) Distribution of mast cells in human dermis: development of a mapping technique. Br J Dermatol 100:635–640
Denda M, Tsuchiya T, Hosoi J, Koyama J (1998) Immobilization-induced and crowded environment-induced stress delay barrier recovery in murine skin. Br J Dermatol 138:780–785
Dhabhar FS, Malarkey WB, Neri E, McEwen BS (2012) Stress-induced redistribution of immune cells–from barracks to boulevards to battlefields: a tale of three hormones–Curt Richter award winner. Psychoneuroendocrinology 37:1345–1368
Dhabhar FS, McEwen BS (1997a) Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 11:286–306
Dhabhar FS, McEwen BS (1997b) Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 11:286–306
Dhabhar FS, McEwen BS (1999) Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 96:1059–1064
Dhabhar FS, Miller AH, McEwen BS, Spencer RL (1995) Effects of stress on immune cell distribution dynamics and hormonal mechanisms. J Immunol 154:5511–5527
Dhabhar FS, Miller AH, Stein M, McEwen BS, Spencer RL (1994) Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav Immun 8:66–79
Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, Noubade R, Briso EM, Charland C, Leonard WJ, Ciliberto G, Teuscher C, Haynes L, Rincon M (2009) The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4 + T cells. J Exp Med 206:69–78
Eady RA, Cowen T, Marshall TF, Plummer V, Greaves MW (1979) Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 100:623–633
Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP (1996) Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Phys 108:374–381
Flint MS, Tinkle SS (2001) C57BL/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivity. Toxicol Sci 62:250–256
Fortune DG, Richards HL, Griffiths CE, Main CJ (2004) Targeting cognitive-behaviour therapy to patients’ implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 43:65–82
Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR, Elias PM (2001) Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 137:53–59
Graham HT, Lowry OH, Wahl N, Priebat MK (1955) Mast cells as sources of tissue histamine. J Exp Med 102:307–318
Grammatopoulos DK, Chrousos GP (2002) Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13:436–444
Grewe M, Bruijnzeel-Koomen CAFM, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19:359–361
Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, Ruby CM, Schmader KE (2003) Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 1:82–89
Hall JM, Witter AR, Racine RR, Berg RE, Podawiltz A, Jones H, Mummert ME (2014) Chronic psychological stress suppresses contact hypersensitivity: Potential roles of dysregulated cell trafficking and decreased IFN-gamma production. Brain Behav Immun 36:156–164
Hanifin, J.M., Reed, M.L., Eczema Prevalence and Impact Working Group (2007) A population-based survey of eczema prevalence in the United States. Dermatitis 18:82–91
Heller MM, Lee ES, Koo JY (2011) Stress as an influencing factor in psoriasis. Skin Ther Lett 16:1–4
Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Burger A (2004) Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 122:673–684
Hosoi J, Tsuchiya T, Denda M, Ashida Y, Takashima A, Granstein RD, Koyama J (1998) Modification of LC phenotype and suppression of contact hypersensitivity response by stress. J Cutan Med Surg 3:79–84
Hsu SY, Hsueh AJ (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605–611
Huang M, Berry J, Kandere K, Lytinas M, Karalis K, Theoharides TC (2002) Mast cell deficient W/W(v) mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int J Immunopathol Pharmacol 15:249–254
Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, Straub RH, Paus R (2005) Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 19:1332–1334
Ives DG, Kuller LH, Schulz R, Traven ND, Lave JR (1992) Comparison of recruitment strategies and associated disease prevalence for health promotion in rural elderly. Prev Med 21:582–591
Jafferany M (2007) Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 9:203–213
Joachim RA, Kuhlmei A, Dinh QT, Handjiski B, Fischer T, Peters EM, Klapp BF, Paus R, Arck PC (2007) Neuronal plasticity of the “brain-skin connection”: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med (Berl) 85:1369–1378
Kagiwada K, Chida D, Sakatani T, Asano M, Nambu A, Kakuta S, Iwakura Y (2004) Interleukin (IL)-6, but not IL-1, induction in the brain downstream of cyclooxygenase-2 is essential for the induction of febrile response against peripheral IL-1alpha. Endocrinology 145:5044–5048
Kalow W (1982) Ethnic differences in drug metabolism. Clin Pharmacokinet 7:373–400
Kariagina A, Romanenko D, Ren SG, Chesnokova V (2004) Hypothalamic-pituitary cytokine network. Endocrinology 145:104–112
Kellogg DL Jr (2006) In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 100:1709–1718
Kitani A, Hara M, Hirose T, Harigai M, Suzuki K, Kawakami M, Kawaguchi Y, Hidaka T, Kawagoe M, Nakamura H (1992) Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 88:75–83
Kleyn CE, Schneider L, Saraceno R, Mantovani C, Richards HL, Fortune DG, Cumberbatch M, Dearman RJ, Terenghi G, Kimber I, Griffiths CE (2008) The effects of acute social stress on epidermal Langerhans’ cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol 128:1273–1279
Kono M, Nagata H, Umemura S, Kawana S, Osamura RY (2001) In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 15:2297–2299
Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R (2010) Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab 21:569–577
Lange-Asschenfeldt C, Grohmann R, Lange-Asschenfeldt B, Engel RR, Ruther E, Cordes J (2009) Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program. J Clin Psychiatry 70:1258–1265
Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19:514–520
Locala JA (2009) Current concepts in psychodermatology. Curr. Psychiatry Rep. 11:211–218
Marks R (2004) The stratum corneum barrier: the final frontier. J Nutr 134:2017S–2021S
Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77:1690–1694
Mason AA (1952) A case of congenital ichthyosiform erythrodermia of brocq treated by hypnosis. Br Med J 2:422–423
Mitkov MV, Trowbridge RM, Lockshin BN, Caplan JP (2014) Dermatological side effects of psychtropic medications. Psychosomatics 55:1–20
Miyazaki Y, Yokozeki H, Awad S, Igawa K, Minatohara K, Satoh T, Katayama I, Nishioka K (2000) Glucocorticoids augment the chemically induced production and gene expression of interleukin-1α through NF-kB and AP-1 activation in murine epidermal cells. J Invest Dermatol 115:746–752
Nakano Y (2007) Effect of chronic topical exposure to low-dose noxious chemicals and stress on skin sensitivity in mice. J Occup Health 49:431–442
Panina-Bordignon P, Mazzeo D, Lucia PD, D’Ambrosio D, Lang R, Fabbri L, Self C, Sinigaglia F (1997) ß2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100:1513–1519
Pergola PE, Kellogg DL Jr, Johnson JM, Kosiba WA, Solomon DE (1993) Role of sympathetic nerves in the vascular effects of local temperature in human forearm skin. Am J Physiol 265:H785–H792
Peters EM, Botchkarev VA, Botchkareva NV, Tobin DJ, Paus R (2001) Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol 116:236–245
Raber J, Sorg O, Horn TF, Yu N, Koob GF, Campbell IL, Bloom FE (1998) Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function. Brain Res Rev 26:320–326
Ramot Y, Biro T, Tiede S, Toth BI, Langan EA, Sugawara K, Foitzik K, Ingber A, Goffin V, Langbein L, Paus R (2010) Prolactin–a novel neuroendocrine regulator of human keratin expression in situ. FASEB J 24:1768–1779
Schutz B, von Engelhardt J, Gordes M, Schafer MK, Eiden LE, Monyer H, Weihe E (2008) Sweat gland innervation is pioneered by sympathetic neurons expressing a cholinergic/noradrenergic co-phenotype in the mouse. Neuroscience 156:310–318
Segerstrom SC (2008) Social networks and immunosuppression during stress: Relationship conflict or energy conservation? Brain Behav Immun 22:279–284
Seiffert K, Granstein RD (2006) Neuroendocrine regulation of skin dendritic cells. Ann NY Acad Sci 1088:195–206
Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K, Wagner JA, Granstein RD (2002) Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 168:6128–6135
Shenefelt PD (2003) Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther 16:114–122
Shenefelt PD (2000) Hypnosis in dermatology. Arch Dermatol 136:393–399
Shenefelt PD (2011) Psychodermatological disorders: recognition and treatment. Int J Dermatol 50:1309–1322
Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC (1999) Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav Immun 13:225–239
Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J (2004) Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145:941–950
Slominski A, Roloff B, Curry J, Dahiya M, Szczesniewski A, Wortsman J (2000a) The skin produces urocortin. J Clin Endocrinol Metab 85:815–823
Slominski A, Szczesniewski A, Wortsman J (2000b) Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab 85:3582–3588
Slominski A, Tobin DJ, Zmijewski MA, Wortsman J, Paus R (2008) Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 19:17–24
Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S (1998) Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 161:4652–4660
Tausk F, Elenkov I, Moynihan J (2008) Psychoneuroimmunology. Dermatol Ther 21:22–31
Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC, Bruijnzeel-Koomen CA (1996) Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 97:828–837
Tsagarakis S, Navarra P, Rees LH, Besser M, Grossman A, Navara P (1989) Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro. Endocrinology 124:2330–2335
Tsigos C, Chrousos GP (2002) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865–871
Ullman M (1947) Herpes simplex and second degree burn induced under hypnosis. Am J Psych 103:828–830
Weihe E, Schutz B, Hartschuh W, Anlauf M, Schafer MK, Eiden LE (2005) Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system. J Comp Neurol 492:370–379
Whitnall MH (1993) Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40:573–629
Wistar R Jr, Hildemann WH (1960) Effect of stress on skin transplantation immunity in mice. Science 131:159–160
Yanagawa Y, Matsumoto M, Togashi H (2010) Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3 K activation following brief exposure to noradrenaline. J Immunol 185:5762–5768
Zimmerman BG, Whitmore L (1967) Transmitter release in skin and muscle blood vessels during sympathetic stimulation. Am J Physiol 212:1043–1054
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mummert, M.E. (2016). Psychological Stress as a Determinant of Skin Barrier Function: Immunological Pathways and Therapeutic Opportunities. In: Wondrak, G. (eds) Skin Stress Response Pathways. Springer, Cham. https://doi.org/10.1007/978-3-319-43157-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-43157-4_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43155-0
Online ISBN: 978-3-319-43157-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)